5-Hydroxytryptamine and dopamine pathways in mania: a pilot study of fenfluramine and pimozide.
作者信息
Cookson J, Silverstone T
出版信息
Br J Clin Pharmacol. 1976 Oct;3(5):942-3. doi: 10.1111/j.1365-2125.1976.tb00654.x.
Abstract
摘要
相似文献
1
5-Hydroxytryptamine and dopamine pathways in mania: a pilot study of fenfluramine and pimozide.
Br J Clin Pharmacol. 1976 Oct;3(5):942-3. doi: 10.1111/j.1365-2125.1976.tb00654.x.
2
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide.
Psychopharmacology (Berl). 1980;67(3):297-305. doi: 10.1007/BF00431272.
3
Dopamine and 5-hydroxytryptamine inhibit feeding in rats.
Nat New Biol. 1973 Nov 14;246(150):52-3. doi: 10.1038/newbio246052a0.
4
A dopaminergic mechanism in mania.
Am J Psychiatry. 1976 Oct;133(10):1177-80. doi: 10.1176/ajp.133.10.1177.
5
Characterisation of adjustments to the structure of feeding behaviour following pharmacological treatment: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and methergoline.
Pharmacol Biochem Behav. 1980 May;12(5):717-22. doi: 10.1016/0091-3057(80)90155-0.
6
Drug-induced changes of brain serotoninergic tone and insulin-induced growth hormone release in the dog.
Neuroendocrinology. 1978;25(2):84-104. doi: 10.1159/000122732.
7
Plasma corticosteroids in mania: the effects of pimozide.
Neuropharmacology. 1980 Dec;19(12):1243-4. doi: 10.1016/0028-3908(80)90218-x.
8
d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.
Am J Psychiatry. 1996 Nov;153(11):1460-3. doi: 10.1176/ajp.153.11.1460.
9
Fenfluramine in man: hypophagia associated with diminished serotonin turnover.
Clin Pharmacol Ther. 1975 May;17(5):616-21. doi: 10.1002/cpt1975175616.
10
The clinical pharmacology of appetite--its relevance to psychiatry.
Psychol Med. 1983 May;13(2):251-3. doi: 10.1017/s0033291700050856.
引用本文的文献
1
Neurochemical and psychoanalytical approaches to mania.
Proc R Soc Med. 1977;70(Suppl 10):20-5. doi: 10.1177/0035915777070S1004.
2
Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man.
J Neural Transm. 1985;61(1-2):81-94. doi: 10.1007/BF01253053.
本文引用的文献
1
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
Eur J Pharmacol. 1970;11(3):303-14. doi: 10.1016/0014-2999(70)90006-3.
2
Amines and abnormal mood.
Proc R Soc Med. 1969 Nov;62(11 Part 1):1102-7. doi: 10.1177/003591576906211P116.
3
Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid.
Arch Gen Psychiatry. 1974 Nov;31(5):649-54. doi: 10.1001/archpsyc.1974.01760170049008.
4
L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders.
Arch Gen Psychiatry. 1974 Jan;30(1):56-62. doi: 10.1001/archpsyc.1974.01760070040006.
5
The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle.
Ergeb Physiol. 1972;64:166-307. doi: 10.1007/3-540-05462-6_2.
6
Neuropharmacology of the affective disorders.
Annu Rev Pharmacol. 1973;13:427-54. doi: 10.1146/annurev.pa.13.040173.002235.
7
Methysergide in mania. A controlled trial.
Lancet. 1969 Aug 16;2(7616):338-40. doi: 10.1016/s0140-6736(69)92697-x.
8
Fenfluramine in mania.
Lancet. 1973 Feb 24;1(7800):427. doi: 10.1016/s0140-6736(73)90284-5.
9
Reduced central serotonergic activity in mania: implications for the relationship between depression and mania.
Br J Psychiatry. 1975 Mar;126:241-8. doi: 10.1192/bjp.126.3.241.
Zotero 插件